139264-69-0

Basic information

• Product Name: Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)
• Synonyms: Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol);ZolMitriptan USP RC B;(S)-β-AMino-3-[2-(diMethylaMino)ethyl]-1H-indole-5-propanol;ZolMitriptan Related CoMpound B;(betaS)-beta-Amino-3-[2-(dimethylamino)ethyl]-1H-indole-5-propanol;(2S)-2-amino-3-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]propan-1-ol;(S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol
• CAS NO: 139264-69-0
• Molecular Formula: C15H23N3O
• Molecular Weight: 261.36262
• Product Categories: Amines, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 139264-69-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)(CAS DataBase Reference)
• NIST Chemistry Reference: Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)(139264-69-0)
• EPA Substance Registry System: Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)(139264-69-0)

Safety Data

• Hazardous Substances Data: 139264-69-0(Hazardous Substances Data)

Usage

Description

Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-3-[2-(dimethylamino)ethyl]-1H-indol-5-ylpropan-1-ol) is a compound related to Zolmitriptan (Z639000), which is a Serotonin 5HT1D-receptor agonist. It is a derivative of the primary medication used for the treatment of migraines and cluster headaches. Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-3-[2-(dimethylamino)ethyl]-1H-indol-5-ylpropan-1-ol) is characterized by its ability to selectively bind to and activate the 5HT1D receptor, which plays a crucial role in modulating the pain pathways associated with these conditions.

Uses

Used in Pharmaceutical Industry:
Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-3-[2-(dimethylamino)ethyl]-1H-indol-5-ylpropan-1-ol) is used as an active pharmaceutical ingredient for the development of medications targeting migraine and cluster headache treatment. Its application is based on its agonistic action on the 5HT1D receptor, which helps alleviate the symptoms of these conditions by constricting blood vessels and reducing the release of pro-inflammatory neuropeptides.
Used in Research and Development:
In the field of scientific research, Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-3-[2-(dimethylamino)ethyl]-1H-indol-5-ylpropan-1-ol) serves as a valuable compound for studying the mechanisms of migraine and cluster headache pathophysiology. It can be utilized in various in vitro and in vivo experiments to investigate the receptor binding, signal transduction pathways, and potential therapeutic effects of novel drug candidates.
Used in Drug Synthesis and Optimization:
Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-3-[2-(dimethylamino)ethyl]-1H-indol-5-ylpropan-1-ol) can be employed as a starting material or a key intermediate in the synthesis of new, potentially more effective, and safer medications for the treatment of migraines and cluster headaches. Its structural features can be modified to improve pharmacokinetic properties, reduce side effects, and enhance the overall efficacy of the resulting drug molecules.